In 2025, the Russian industry generated USD 17.72 billion.
The Russia Infusion Services Market is anticipated to reach USD 45.96 billion by 2033, delivering a CAGR of 12.7% through the projection period.
Public hospital dominance continues to shape infusion delivery, with oncology and hematology driving the majority of systemic therapy administration under federal healthcare programs.
The Russian Ministry of Health reports sustained cancer incidence levels, reinforcing steady infusion utilization across state-funded facilities.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]